Nutritional support for acute respiratory failure in intensive care for the novel coronavirus infection COVID-19

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Severe metabolic disorders caused by COVID-19 require adequate nutritional support. The article discusses the effectiveness of the use of a specialized enteral nutrition mixture in patients with viral pneumonia and acute respiratory distress syndrome caused by COVID-19. 67 patients have been divided into 2 groups according to the nature of enteral nutritional support: a specialized mixture and a standard one. The effectiveness of the mixtures used was evaluated taking into account changes in the level of enzymes, hormonal status, and the functional state of the gastrointestinal tract. Diagnosis of lung pathology was carried out on the basis of computed tomography data and criteria for acute pulmonary injury syndrome. It was found that the inclusion of a specialized mixture, adapted to the pathology of the lungs, into the complex therapy, corrects the violation of homeostasis, helps to reduce the time for resolution of the syndrome of acute pulmonary injury / acute respiratory distress syndrome, artificial ventilation of the lungs and the duration of treatment in the intensive care unit.

About the authors

A. E. Shestopalov

The N.N.Burdenko Main Military Clinical Hospital of the Ministry of Defense of the Russian Federation; Russian Medical Academy of Continuing Professional Education of the Ministry of Health of the Russian Federation

Author for correspondence.
Email: ashest@yandex.ru

заслуженный врач РФ, профессор, полковник медицинской службы в отставке

Russian Federation, Moscow; Moscow

V. V. Stets

The N.N.Burdenko Main Military Clinical Hospital of the Ministry of Defense of the Russian Federation

Email: stetsv@gmail.com

заслуженный врач РФ, полковник медицинской службы

Russian Federation, Moscow

D. V. Davydov

The N.N.Burdenko Main Military Clinical Hospital of the Ministry of Defense of the Russian Federation

Email: ashest@yandex.ru

профессор, полковник медицинской службы

Russian Federation, Moscow

V. A. Chernetsov

The N.N.Burdenko Main Military Clinical Hospital of the Ministry of Defense of the Russian Federation

Email: ashest@yandex.ru

заслуженный врач РФ, доктор медицинских наук, полковник медицинской службы

Russian Federation, Moscow

A. N. Ilichev

The N.N.Burdenko Main Military Clinical Hospital of the Ministry of Defense of the Russian Federation

Email: ashest@yandex.ru

заслуженный врач РФ, подполковник медицинской службы

Russian Federation, Moscow

A. G. Zhuravlev

The N.N.Burdenko Main Military Clinical Hospital of the Ministry of Defense of the Russian Federation

Email: ashest@yandex.ru

кандидат медицинских наук, подполковник медицинской службы

Russian Federation, Moscow

V. A. Zyryanov

The N.N.Burdenko Main Military Clinical Hospital of the Ministry of Defense of the Russian Federation

Email: ashest@yandex.ru

подполковник медицинской службы

Russian Federation, Moscow

V. V. Morgachev

The N.N.Burdenko Main Military Clinical Hospital of the Ministry of Defense of the Russian Federation

Email: ashest@yandex.ru
Russian Federation, Moscow

N. G. Arykan

Russian Medical Academy of Continuing Professional Education of the Ministry of Health of the Russian Federation

Email: ashest@yandex.ru
Russian Federation, Moscow

References

  1. Зайцев А.А., Чернов С.А., Стец В.В., Паценко М.Б., Кудряшов О.И., Чернецов В.А., Крюков Е.В. Алгоритмы ведения пациентов с новой коронавирусной инфекцией COVID-19 в стационаре: Метод. реком. // Consilium Medicum. – 2020. – Т. 22, № 11. – С. 91–97.
  2. Калмыкова З.А., Кононенко И.В., Скляник И.А. и др. Гипергликемия и возможные механизмы повреждения β-клеток у пациентов с COVID-19 // Сахарный диабет. – 2020. – Т. 23, № 3. – С. 229–234.
  3. Клинические рекомендации по ведению тяжелого острого респираторного синдрома (ТОРС, ТОРИ, SARI), обусловленного новой коронавирусной инфекцией (COVID-19) / ВОЗ. – 13.03.2020.
  4. Кувшинов К.Э., Щеголев А.В., Мирошниченко Ю.В. и др. Нутриционная поддержка при проведении интенсивной терапии в военно-медицинских организациях МО РФ: Методические указания. – М., 2016. – С. 93.
  5. Мачулина И.А., Шестопалов А.Е., Евдокимов Е.А. Терапия тяжелой кишечной недостаточности: основные этапы и роль фармаконутриентов // Мед. алфавит. – 2020. – № 7. – С. 49–52.
  6. Нутритивная поддержка пациентов с коронавирусной инфекцией COVID-19: Методические рекомендации. – М.–Тверь: Изд-во «Триада». – 2020. – С. 92.
  7. Шестопалов А.Е. Современные подходы к периоперационной нутритивной поддержке в онкохирургии // Вестн. интенсив. терапии. – 2016. – № 2. – С. 5–14.
  8. Ярошецкий А.И., Грицан А.И., Авдеев С.Н. и др. Диагностика и интенсивная терапия острого респираторного дистресс-синдрома (Клинические рекомендации Общероссийской общественной организации «Федерация анестезиологов и реаниматологов») // Анестезиология и реаниматология. – 2020. – № 2. – С. 5–39.
  9. Allard L., Ouedraоgo E., Molleyille J. et al. Malnutrition: Percentage and Association with Prognosis in Patients Hospitalized for Coronavirus Disease 2019 // Nutrients. – 2020. – Vol. 12, Iss. 12. – Р. 3679.
  10. Bode B., Garrett V., Messler J. et al. Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States // J. Diabetes Sci. Technol. – 2020. – Vol. 14, N 4. – Р. 813–821.
  11. Chen G., Wu D., Guo W. et al. Clinical and immunological features of severe and moderate coronavirus disease 2019// J. Clin. Invest. – 2020. – Vol. 130, N 5. – Р. 2620–2629.
  12. Guan W., Ni Z., Hu Y. et al. Clinical characteristics of coronavirus disease 2019 in China // N. Engl. J. Med. – 2020. – Vol. 382. – Р. 1708–1720.
  13. Hodgson C., Goligher E.C., Young M.E. Cochrane Clinical AnswersQuestion: For adults with acute respiratory distress syndrome (ARDS) who are mechanically ventilated, how does immunonutrition compare with standard formula feeding? // 2019. – https://doi.org/10.1002/14651858.CD006667.pub3
  14. Iacobellis G., Penaherrera C.A., Bermudez L.E. et al. Admission hyperglycemia and radiological findings of SARS-CoV2 in patients with and without diabetes // Diabetes Res. Clin. Pract. – 2020. – Vol. 164. – Р. 1081–1085.
  15. Jin Y., Yang H., Ji W. et al. Virology, epidemiology, pathogenesis, and control of COVID-19 // Viruses. – 2020. – Vol. 12, N 4. – Р. 372.
  16. Marini J.J., Rocco P.R.M., Gattinoni L. Static and dynamic contributors to ventilator-induced lung injury in clinical practice. pressure, energy, and power // Am. J. Respir. Crit. Care Med. – 2020. – Vol. 201, N 7. – Р. 767–774.
  17. Matthay M.A., Aldrich J.M., Gotts J.E. Treatment for severe acute respiratory distress syndrome from COVID-19 // Lancet Respir. Med. – 2020. – Vol. 8, N 5. – Р. 433–434.
  18. Murray J.F., Matthey M.A., Luce J.M. et al. An expanded definition of the adult respiratory distress syndrome // Amer. Rev. Resp. Dis. – 1988. – Vol. 138, N 3. – P. 720–723.
  19. Muscaritoli M., Anker S.D., Argilйs J. et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”// Clin. Nutr. – 2019. – Vol. 29, N 2. – Р. 154–159.
  20. Ramanathan K., Antognini D., Combes A. et al. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases // Lancet Respir. Med. – 2020. – Vol. 8, N 5. – Р. 518–526.
  21. Romano L., Bilotta F., Dauri M. et al. Short report – medical nutrition therapy for critically ill patients with COVID-19 // Eur. Rev. Med. Pharmacol. Sci. – 2020. – Vol. 24, N 7. – Р. 4035–4039.
  22. Singer P., Reintam Blaser A., Berger M. et al. ESPEN guideline on clinical nutrition in the intensive care unit // Clin. Nutr. – 2019. – Vol. 38. – Р. 48–70.
  23. Stachowska E., Folwarski M., Jamioі-Milc D. et al. Nutritional support in coronavirus 2019 disease // Medicina (Kaunas). – 2020. – Vol. 56, N 6. – Р. 289.
  24. Thaweerat W. Current evidence on pancreatic involvement in SARS-CoV-2 infection // Pancreatology. – 2020. – Vol. 20, N 5. – Р. 1013–1014.
  25. Vieillard-Baron A., Matthay M., Teboul J.L. et al. Experts’ opinion on management ofhemodynamics in ARDS patients: focus on the effects of mechanical ventilation // Intensive Care Med. 2016. – Vol. 42, N 5. – Р. 739–749.
  26. Virgens I. P.A., Santana N.M., Lima S.C.V.C. et al. Can COVID-19 be a risk for cachexia for patients during intensive care? Narrative review and nutritional recommendations // Br. J. Nutr. – 2021. – Vol. 126, N 4. – Р. 552–560.
  27. Wu C., Chen X., Cai Y. et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in wuhan, china // JAMA. Intern. Med. – 2020. – Vol. 180, N 7. – Р. 934–943.
  28. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China // JAMA. – 2020. – Vol. 323, N 13. – Р. 1239–1242.
  29. Yang W., Cao Q., Qin L. et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang, China // J. Infect. – 2020. – Vol. 80, N 4. – Р. 388–3 93.
  30. Zhu J., Ji P., Pang J. et al. Clinical characteristics of 3062 COVID-19 patients: a meta- analysis // J. Med. Virol. – 2020. – Vol. 92, N 10. – Р. 1902–1914.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 Shestopalov A.E., Stets V.V., Davydov D.V., Chernetsov V.A., Ilichev A.N., Zhuravlev A.G., Zyryanov V.A., Morgachev V.V., Arykan N.G.


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: № 01975 от 30.12.1992.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies